Sensus Healthcare (SRTS) Competitors

Neuronetics (NASDAQ:STIM) and Sensus Healthcare (NASDAQ:SRTS) are both small-cap medical companies, but which is the superior business? We will contrast the two businesses based on the strength of their institutional ownership, media sentiment, risk, profitability, analyst recommendations, valuation, earnings and dividends.

Do insiders & institutionals have more ownership in STIM or SRTS?

53.6% of Neuronetics shares are owned by institutional investors. Comparatively, 25.3% of Sensus Healthcare shares are owned by institutional investors. 8.7% of Neuronetics shares are owned by insiders. Comparatively, 8.9% of Sensus Healthcare shares are owned by insiders. Strong institutional ownership is an indication that endowments, large money managers and hedge funds believe a stock will outperform the market over the long term.

Do analysts recommend STIM or SRTS?

Neuronetics presently has a consensus target price of $7.00, indicating a potential upside of 111.48%. Sensus Healthcare has a consensus target price of $8.00, indicating a potential upside of 151.57%. Given Sensus Healthcare's higher probable upside, analysts plainly believe Sensus Healthcare is more favorable than Neuronetics.

Company	Sell Ratings	Hold Ratings	Buy Ratings	Strong Buy Ratings	Rating Score
Neuronetics	0 Sell rating(s)	0 Hold rating(s)	1 Buy rating(s)	0 Strong Buy rating(s)	3.00
Sensus Healthcare	0 Sell rating(s)	0 Hold rating(s)	3 Buy rating(s)	0 Strong Buy rating(s)	3.00

Which has higher earnings and valuation, STIM or SRTS?

Sensus Healthcare has lower revenue, but higher earnings than Neuronetics. Sensus Healthcare is trading at a lower price-to-earnings ratio than Neuronetics, indicating that it is currently the more affordable of the two stocks.

Company	Gross Revenue	Price/Sales Ratio	Net Income	Earnings Per Share	Price/Earnings Ratio
Neuronetics	$74.89M	2.92	-$43.71M	-$1.13	-2.93
Sensus Healthcare	$41.81M	1.25	$6.65M	-$0.06	-53.00

Which has more volatility and risk, STIM or SRTS?

Neuronetics has a beta of 1.28, indicating that its stock price is 28% more volatile than the S&P 500. Comparatively, Sensus Healthcare has a beta of 1.41, indicating that its stock price is 41% more volatile than the S&P 500.

Is STIM or SRTS more profitable?

Sensus Healthcare has a net margin of -2.26% compared to Neuronetics' net margin of -43.47%. Sensus Healthcare's return on equity of -1.58% beat Neuronetics' return on equity.

Company	Net Margins	Return on Equity	Return on Assets
Neuronetics	-43.47%	-156.36%	-35.69%
Sensus Healthcare	-2.26%	-1.58%	-1.41%

Does the media refer more to STIM or SRTS?

In the previous week, Neuronetics and Neuronetics both had 4 articles in the media. Neuronetics' average media sentiment score of 1.40 beat Sensus Healthcare's score of 0.00 indicating that Neuronetics is being referred to more favorably in the media.

Company	Very Positive	Positive	Neutral	Negative	Very Negative	Overall Sentiment
Neuronetics	3 Very Positive mention(s)	0 Positive mention(s)	1 Neutral mention(s)	0 Negative mention(s)	0 Very Negative mention(s)	Positive
Sensus Healthcare	0 Very Positive mention(s)	0 Positive mention(s)	4 Neutral mention(s)	0 Negative mention(s)	0 Very Negative mention(s)	Neutral

Summary

Sensus Healthcare beats Neuronetics on 9 of the 14 factors compared between the two stocks.